{"news_desk": "Business", "print_page": "3", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By MICHAEL J. de la MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "de la MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "Teva Pharmaceuticals is in talks to acquire Allergan for $45 billion, which, if successful, would bolster Teva's position in generic drug market.", "type_of_material": "News", "word_count": "404", "lead_paragraph": "The $45 billion deal, if successful, would be the latest in health care, where drug makers, insurers and others have been involved in a spate of mergers.", "pub_date": "2015-07-27T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva Said to Be Close to Buying Generic Drug Unit of Allergan", "print_headline": "Teva, Already a Giant in Generics, Is in Talks to Buy Allergan&#8217;s Division "}, "snippet": "The $45 billion deal, if successful, would be the latest in health care, where drug makers, insurers and others have been involved in a spate of mergers.", "multimedia": [{"height": 126, "url": "images/2015/07/27/business/27teva/27teva-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/07/27/business/27teva/27teva-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/07/27/business/27teva/27teva-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/07/27/business/27teva/27teva-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/07/27/business/27teva/27teva-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/07/27/business/27teva/27teva-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/07/27/business/teva-said-to-be-close-to-buying-generic-drug-unit-of-allergan.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "55b43e9d38f0d851b1f6dc9d", "source": "The New York Times"}